Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Microbiota 9 - March 2020
  3. Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Microbiota 9 - March 2020
  3. Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease
Gastroenterology

Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease

IBD

Commented articles - Adult's section

By Pr. Harry Sokol
Gastroenterology and Nutrition Department, Saint-Antoine Hospital, Paris, France

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

Bacteriophages infecting bacteria, illustration. A bacteriophage, or phage, is a virus that infects bacteria.

About this article

Created 25 August 2021
Updated 05 January 2022

Commentary on the original publication by Clooney et al. (Cell Host & Microbe 2019) [1]

The human gut virome is thought to significantly impact the microbiome and human health. However, most analyses have been performed on a limited fraction of known viruses. Using whole-virome analysis on a published inflammatory bowel disease (IBD) cohort and an in-house ulcerative colitis dataset, the authors shed light on the composition of the human gut virome in IBD beyond this identifiable minority. They observed IBD-specific changes to the virome and increased numbers of temperate phage sequences in individuals with Crohn’s disease. Unlike prior database-dependent methods, no changes in viral richness were observed. Among IBD subjects, the changes in virome composition reflected alterations in bacterial composition. Furthermore, incorporating both bacteriome and virome composition offered greater classification power between health and disease. This approach to analyzing whole virome across cohorts highlights significant IBD signals, which may be crucial for developing future biomarkers and therapeutics.

What do we already know about this subject?

The virome is probably one of the main forces that shape the human gut microbiome, but it may also be its least understood component. The virome is composed mostly of bacteriophages (phages), which play a key role in many microbial ecosystems by stimulating diversity, helping to replenish nutrients and facilitating horizontal gene transfer. Understanding the role of bacteriophages in the structures of microbial communities will be essential if we are to understand and control the alterations in the human gut microbiome that are associated with various diseases. Many gut bacteria (and potential phage hosts) are difficult to grow in the laboratory, which means that virome analysis is highly dependent on metagenomic sequencing and bioinformatic approaches.

Key points

  • A large majority of the gut virome cannot be studied because it is absent from the databases.

  • The database-independent method described here allows analysis of the whole gut virome.

  • In IBD, the gut virome is altered, less stable, and dominated by temperate phages.

  • The gut virome could be used as biomarker or therapeutics in the future.

However, phages lack universal marker genes (like the 16S rRNA gene found in bacteria), and there is a lack of taxonomic information with sparse databases, which means that methods are needed that are independent of databases. The first metagenomic studies revealed the diversity of the human gut virome, but could only classify a very small fraction (2%) of the DNA sequenced.[2] Improvements in high throughput sequencing technologies now make it possible to analyze the virome with an unprecedented level of detail. It has been confirmed that the virome is incredibly diverse, that the majority do not align to any reference virus sequences in databases (referred to as viral dark matter), and that the composition is unique to individuals.

Although the etiology of IBD remains unclear, these diseases are multifactorial and associated with alterations in the gut microbiome. Emerging data now indicate that the gut virome is altered in IBD [3] with greater overall diversity and an increased relative abundance of the order Caudovirales. However, almost all the results have been based on changes in the composition of the identifiable fraction of the virome, which can represent as little as 15% of the dataset.[3] This limits our overall understanding of the virome and hinders the identification of potential disease biomarkers. An analytical method independent of databases is essential if we want to fully characterize the alterations in the gut virome.

Image

What are the main insights from this study?

The authors of this study re-analyzed a set of published keystone data [3] from a Crohn’s disease and ulcerative colitis cohort and from healthy controls. The problem of high interindividual variation was overcome by using protein homology and a specific algorithm (Markov cluster) to group the viral sequences into presumed taxonomic ranks. This made it possible to describe changes in composition across the whole virome beyond the identifiable minority. The authors suggest that unlike the core virome of healthy subjects composed of virulent phages, the virome of IBD subjects is altered, less stable, and dominated by temperate phages. They show that changes in the virome reflect alterations in the bacteriome and that the use of both the bacteriome and virome composition was more effective at differentiating between IBD and healthy subjects (Figure 1). The results were validated on a longitudinal ulcerative colitis cohort. This database-independent approach could be used to shed light on viral dark matter from many published studies.

What are the consequences in practice

These findings confirm that the human gut virome is altered in IBD and that this may be associated with members of the bacterial microbiota; this could be used as a diagnostic or even prognostic biomarker. In addition, the observed alterations suggest that the virome could be partly responsible for the alterations in the bacterial microbiota seen in IBD. To this end, the gut virome could therefore be a future target or a future therapeutic tool in IBD.

Conclusion

Using a database-independent method, the whole gut virome can be studied whereas usually only a minority is analyzed. While the core virome in healthy subjects consists of virulent phages, the virome in IBD is altered, less stable, and dominated by temperate phages. Using both the virome and the bacterial microbiota composition makes it possible to differentiate IBD patients from healthy subjects more effectively than by using only one or the other. These results open new perspectives for the use of the virome as biomarker or therapeutic target in IBD.

Sources

1 Clooney AG, Sutton TDS, Shkoporov AN, et al. Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease. Cell Host Microbe 2019 ; 26 : 764-78.

2 Minot S, Sinha R, Chen J, et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res 2011 ; 21 : 1616-25.

3 Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015 ; 160 : 447-60.

Tags
Gastroenterology Virome

en_view en_sources

    Focus
    Microbiota 9 - March 2020
    • Overview
      • Impact of antibiotics on the gut microbiota, does it matter?
    • Commented articles
      • Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease
      • Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota
    • Congress review
      • UEG Week 2019 - Intestinal microbiota: influencing factors and role in certain pathologies
      • ADPW 2019: The growing importance of gut microbiota on digestive health
    • Press review
      • Implication of vaginal microbiota in bacterial vaginosis and candidiasis
      • Skin microbiota : which role in atopic dermatitis and acne?
      • Modulating gut microbiota in metabolism disorders and alcoholic hepatitis
    Created 25 August 2021
    Updated 05 January 2022

    About this article

    To know more about this topic.

    Main topic

    IBD

    Content type

    Commented article
    Impact of antibiotics on the gut microbiota, does it matter?
    Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota
    Focus

    Microbiota 9 - March 2020

    Overview

    Impact of antibiotics on the gut microbiota, does it matter?

    Commented articles

    Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota

    Congress review

    UEG Week 2019 - Intestinal microbiota: influencing factors and role in certain pathologies ADPW 2019: The growing importance of gut microbiota on digestive health

    Press review

    Implication of vaginal microbiota in bacterial vaginosis and candidiasis Skin microbiota : which role in atopic dermatitis and acne? Modulating gut microbiota in metabolism disorders and alcoholic hepatitis
    Gastroenterology
    L’axe intestin-cerveau dans le stress lié à la discrimination
    20.03.2023

    The gut-brain axis and discrimination-related stress

    Read the article
    20.03.2023

    The role of Bifidobacteria in irritable bowel syndrome (IBS)

    Read the article
    14.03.2023

    Positive impact of running on gut microbiota and adolescent depression

    Read the article
    09.03.2023

    Each subtype of Irritable Bowel Syndrome (IBS) has its own dysbiosis

    Read the article
    Parkinson : le microbiote intestinal, chef d’orchestre des mécanismes pathogéniques ?
    27.02.2023

    Does the gut microbiota orchestrate pathogenic mechanisms in Parkinson’s disease?

    Read the article

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

    Commented article - Children's section By Pr. Emmanuel M...

    Find out more

    Impact of beer and non alcoholic consumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    L’axe intestin-cerveau dans le stress lié à la discrimination
    20.03.2023

    The gut-brain axis and discrimination-related stress

    Read the article
    20.03.2023

    The role of Bifidobacteria in irritable bowel syndrome (IBS)

    Read the article
    14.03.2023

    Positive impact of running on gut microbiota and adolescent depression

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo